Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: an in vivo microdialysis study - PubMed (original) (raw)

. 1996 Dec;354(6):785-90.

doi: 10.1007/BF00166906.

Affiliations

• PMID: 8971740
• DOI: 10.1007/BF00166906

Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: an in vivo microdialysis study

I Malagié et al. Naunyn Schmiedebergs Arch Pharmacol. 1996 Dec.

Abstract

We studied the changes in extracellular serotonin (5-HT) levels in the frontal cortex (FC) and ventral hippocampus (vHi) in conscious rats, induced by the combined administration of a highly selective 5-HT1A receptor antagonist, WAY 100635 (0.1 mg/kg, i.v.), and fluoxetine (1 mg/kg, i.p.), a selective 5-HT reuptake inhibitor (SSRI). In the two brain areas studied, no change in extracellular 5-HT concentrations was observed following fluoxetine administration over the 210 min post-injection period. However, in animals co-administered with [WAY 100635 + fluoxetine], the maximal increase in 5-HT levels in the FC was to 215% of the respective basal value (100%), while no significant change in 5-HT was observed in dialysates from the vHi. Furthermore, the [norfluoxetine]-to-[fluoxetine] ratio in the FC was significantly higher than in the hippocampus as measured in homogenates of animals treated with either fluoxetine alone or a prior administration of WAY 100635. Thus, WAY 100635 made the fluoxetine short-lasting effect apparent in the FC, but not by interfering with pharmacokinetic parameters of fluoxetine. Taken together, our data suggest the possibility, that either 5-HT1A autoreceptor sensitivity or uptake carrier density or higher [metabolite]-to-[parent drug] ratios in the FC than in the hippocampus may be involved in regional specific responses to SSRIs.

PubMed Disclaimer

Similar articles

• Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
  Invernizzi R, Bramante M, Samanin R. Invernizzi R, et al. Pharmacol Biochem Behav. 1996 May;54(1):143-7. doi: 10.1016/0091-3057(95)02159-0. Pharmacol Biochem Behav. 1996. PMID: 8728551
• Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors.
  Hervás I, Artigas F. Hervás I, et al. Eur J Pharmacol. 1998 Sep 25;358(1):9-18. doi: 10.1016/s0014-2999(98)00579-2. Eur J Pharmacol. 1998. PMID: 9809863
• Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
  Sharp T, Umbers V, Gartside SE. Sharp T, et al. Br J Pharmacol. 1997 Jul;121(5):941-6. doi: 10.1038/sj.bjp.0701235. Br J Pharmacol. 1997. PMID: 9222551 Free PMC article.

Cited by

• 5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization.
  Froger N, Gardier AM, Moratalla R, Alberti I, Lena I, Boni C, De Felipe C, Rupniak NM, Hunt SP, Jacquot C, Hamon M, Lanfumey L. Froger N, et al. J Neurosci. 2001 Oct 15;21(20):8188-97. doi: 10.1523/JNEUROSCI.21-20-08188.2001. J Neurosci. 2001. PMID: 11588191 Free PMC article.
• Antidepressant activity: contribution of brain microdialysis in knock-out mice to the understanding of BDNF/5-HT transporter/5-HT autoreceptor interactions.
  Gardier AM. Gardier AM. Front Pharmacol. 2013 Aug 8;4:98. doi: 10.3389/fphar.2013.00098. eCollection 2013. Front Pharmacol. 2013. PMID: 23964240 Free PMC article.
• Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in rats.
  Bari A, Theobald DE, Caprioli D, Mar AC, Aidoo-Micah A, Dalley JW, Robbins TW. Bari A, et al. Neuropsychopharmacology. 2010 May;35(6):1290-301. doi: 10.1038/npp.2009.233. Epub 2010 Jan 27. Neuropsychopharmacology. 2010. PMID: 20107431 Free PMC article.
• Pharmacokinetic and metabolism studies using microdialysis sampling.
  Hansen DK, Davies MI, Lunte SM, Lunte CE. Hansen DK, et al. J Pharm Sci. 1999 Jan;88(1):14-27. doi: 10.1021/js9801485. J Pharm Sci. 1999. PMID: 9874697 Free PMC article. Review. No abstract available.

References

1. 1. Eur J Pharmacol. 1995 Nov 14;286(2):213-7 - PubMed
2. 1. Brain Res. 1992 Jul 3;584(1-2):322-4 - PubMed
3. 1. Synapse. 1987;1(1):3-9 - PubMed
4. 1. J Pharmacol Exp Ther. 1993 Jun;265(3):1319-24 - PubMed
5. 1. J Neurochem. 1993 Feb;60(2):776-9 - PubMed

Publication types

MeSH terms

Substances